Sign up for our newsletter!
Get the latest information and inspirational stories for caregivers, delivered directly to your inbox.
MedicalNewsToday
Gallagher is the senior author of a new study recently published in the journal Alzheimer’s & Dementia: Translational Research & Clinical InterventionsTrusted Source examining the use of a once-a-day investigational medication to treat amnestic mild cognitive impairment — which mainly affects memory — due to Alzheimer’s disease. Researchers found this new drug helped slow brain atrophy progression in people with mild cognitive impairment due to Alzheimer’s disease who are not carriers of the APoE-4 alleleTrusted Source, a genetic variant that linked to increased Alzheimer’s disease risk.
See full story at MedicalNewsToday